152 related articles for article (PubMed ID: 25284368)
1. NMR structure of the water soluble Aβ17-34 peptide.
Fonar G; Samson AO
Biosci Rep; 2014 Nov; 34(6):e00155. PubMed ID: 25284368
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.
Mandal PK; Pettegrew JW
Neurochem Res; 2004 Dec; 29(12):2267-72. PubMed ID: 15672549
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
Coles M; Bicknell W; Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Aug; 37(31):11064-77. PubMed ID: 9693002
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.
Crescenzi O; Tomaselli S; Guerrini R; Salvadori S; D'Ursi AM; Temussi PA; Picone D
Eur J Biochem; 2002 Nov; 269(22):5642-8. PubMed ID: 12423364
[TBL] [Abstract][Full Text] [Related]
5. Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide.
Wei G; Shea JE
Biophys J; 2006 Sep; 91(5):1638-47. PubMed ID: 16766615
[TBL] [Abstract][Full Text] [Related]
6. Molecular simulation of the primary and secondary structures of the Abeta(1-42)-peptide of Alzheimer's disease.
Mager PP
Med Res Rev; 1998 Nov; 18(6):403-30. PubMed ID: 9828040
[TBL] [Abstract][Full Text] [Related]
7. The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding.
Tomaselli S; Esposito V; Vangone P; van Nuland NA; Bonvin AM; Guerrini R; Tancredi T; Temussi PA; Picone D
Chembiochem; 2006 Feb; 7(2):257-67. PubMed ID: 16444756
[TBL] [Abstract][Full Text] [Related]
8. Site-specific identification of non-beta-strand conformations in Alzheimer's beta-amyloid fibrils by solid-state NMR.
Antzutkin ON; Balbach JJ; Tycko R
Biophys J; 2003 May; 84(5):3326-35. PubMed ID: 12719262
[TBL] [Abstract][Full Text] [Related]
9. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
[TBL] [Abstract][Full Text] [Related]
10. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
11. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
12. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Aβ aggregation mechanism probed by congo red.
Wang CC; Huang HB; Tsay HJ; Shiao MS; Wu WJ; Cheng YC; Lin TH
J Biomol Struct Dyn; 2012; 30(2):160-9. PubMed ID: 22702727
[TBL] [Abstract][Full Text] [Related]
14. Structure of the 21-30 fragment of amyloid beta-protein.
Baumketner A; Bernstein SL; Wyttenbach T; Lazo ND; Teplow DB; Bowers MT; Shea JE
Protein Sci; 2006 Jun; 15(6):1239-47. PubMed ID: 16731963
[TBL] [Abstract][Full Text] [Related]
15. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.
Zagorski MG; Barrow CJ
Biochemistry; 1992 Jun; 31(24):5621-31. PubMed ID: 1610809
[TBL] [Abstract][Full Text] [Related]
16. Structures of Aβ17-42 trimers in isolation and with five small-molecule drugs using a hierarchical computational procedure.
Chebaro Y; Jiang P; Zang T; Mu Y; Nguyen PH; Mousseau N; Derreumaux P
J Phys Chem B; 2012 Jul; 116(29):8412-22. PubMed ID: 22283547
[TBL] [Abstract][Full Text] [Related]
17. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
Bokvist M; Lindström F; Watts A; Gröbner G
J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
[TBL] [Abstract][Full Text] [Related]
18. Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins.
Maatuk N; Samson AO
Neurotoxicology; 2013 Jan; 34():236-42. PubMed ID: 23022323
[TBL] [Abstract][Full Text] [Related]
19. Expression and purification of 15N- and 13C-isotope labeled 40-residue human Alzheimer's β-amyloid peptide for NMR-based structural analysis.
Long F; Cho W; Ishii Y
Protein Expr Purif; 2011 Sep; 79(1):16-24. PubMed ID: 21640828
[TBL] [Abstract][Full Text] [Related]
20. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils.
Petkova AT; Yau WM; Tycko R
Biochemistry; 2006 Jan; 45(2):498-512. PubMed ID: 16401079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
